Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Dimenhydrinate
Cat. No.:
OB0225LY-0171
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Dimenhydrinate is an ethanolamine and histamine antagonist.
Synonym:
Dramamine; Chloranautine; Vomex A; 523-87-5
CAS No.:
523-87-5
Formula:
C24H28ClN5O3
Formula Weight:
469.96
Specification
Relative Density:
1.2586 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Dimenhydrinate can be used to study the physiological mechanisms of motion sickness or play an important role in neuroscience research.
Library Information
Targets:
Histamine receptor family
Receptors:
H1 receptor
Pathways:
Neuronal signaling; Immunology/Inflammation; GPCR/G protein
Plate Number:
AOCL-3
Plate Location:
b4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/mL; 127.67 mM
